Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.36 EUR | -6.21% | -16.05% | -43.33% |
Jun. 05 | Mib up at start, DiaSorin good on FDA news | AN |
May. 27 | Milan top pink; banking sector trailing | AN |
Valuation
Fiscal Period: December | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
Capitalization 1 | 35 | 11.9 | 11.9 | - |
Enterprise Value (EV) 1 | 28.33 | 20.8 | 7.099 | 4.899 |
P/E ratio | - | -4.39 x | -5.91 x | 10.5 x |
Yield | - | - | - | - |
Capitalization / Revenue | 7.6 x | 2.21 x | 0.67 x | 0.34 x |
EV / Revenue | 6.15 x | 2.19 x | 0.4 x | 0.14 x |
EV / EBITDA | -36.9 x | -17.3 x | - | 1.02 x |
EV / FCF | -5.33 x | -3.23 x | -7.1 x | 2.58 x |
FCF Yield | -18.8% | -31% | -14.1% | 38.8% |
Price to Book | - | - | - | - |
Nbr of stocks (in thousands) | 8,749 | 8,749 | 8,749 | - |
Reference price 2 | 4.000 | 1.360 | 1.360 | 1.360 |
Announcement Date | 3/23/23 | 3/21/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net sales 1 | - | 4.604 | 9.488 | 17.8 | 35.2 |
EBITDA 1 | - | -0.768 | -1.2 | - | 4.8 |
EBIT 1 | - | -2.182 | -3.9 | -2.5 | 1.7 |
Operating Margin | - | -47.39% | -41.1% | -14.04% | 4.83% |
Earnings before Tax (EBT) 1 | -1.756 | -2.269 | -4.11 | -2.6 | 1.6 |
Net income 1 | -1.219 | -1.587 | -2.745 | -2 | 1.2 |
Net margin | - | -34.47% | -28.93% | -11.24% | 3.41% |
EPS 2 | - | - | -0.3100 | -0.2300 | 0.1300 |
Free Cash Flow 1 | - | -5.318 | -6.446 | -1 | 1.9 |
FCF margin | - | -115.52% | -67.93% | -5.62% | 5.4% |
FCF Conversion (EBITDA) | - | - | - | - | 39.58% |
FCF Conversion (Net income) | - | - | - | - | 158.33% |
Dividend per Share | - | - | - | - | - |
Announcement Date | 4/12/22 | 3/23/23 | 3/21/24 | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - |
Net Cash position 1 | - | 6.67 | 0.2 | 4.8 | 7 |
Leverage (Debt/EBITDA) | - | - | - | - | - |
Free Cash Flow 1 | - | -5.32 | -6.45 | -1 | 1.9 |
ROE (net income / shareholders' equity) | - | -13.7% | -21.1% | -11% | 6% |
ROA (Net income/ Total Assets) | - | - | - | - | - |
Assets 1 | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - |
Capex 1 | - | 4.04 | 4.97 | 2.7 | 2.7 |
Capex / Sales | - | 87.72% | 52.35% | 15.17% | 7.67% |
Announcement Date | 4/12/22 | 3/23/23 | 3/21/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-43.33% | 13.8M | |
+16.88% | 111B | |
+8.62% | 111B | |
+7.96% | 76.12B | |
+24.66% | 29.75B | |
+15.39% | 20.79B | |
-2.59% | 12.16B | |
+3.77% | 10.63B | |
+3.96% | 10.18B | |
+11.83% | 9.16B |
- Stock Market
- Equities
- YOLO Stock
- Financials Yolo Group S.p.A.